DUBLIN – (AFTERNOON PRAYER) – Added report “Global Precision Medicine Market 2021-2028” ResearchAndMarkets.com’s offering.
The publisher predicts that the global market for precision medicine would monitor a CAGR of 9.79% over the estimated period 2021-2028.
The high rate of chronic diseases among the aging population is largely driving the growth of the market studied. In addition, investments by government and private players in the field of cancer and demand for protective care are generating beneficial opportunities for the precision medicine market. Here, advances in technologies have raised awareness of personal health, which has led to an increase in the demand for protective care among people.
However, some factors, such as the strict process for drug licensing, coupled with security threats associated with data sharing, hinder the overall development of the precision medicine market.
The global precision medicine market includes the regions of North America, Asia-Pacific, Latin America, Europe, and the Middle East and Africa.
Asia-Pacific is expected to show the fastest growth rate in the global market over the estimated period. The region’s strong growth is largely due to the rise in awareness of healthcare coupled with positive diagnostic procedures. In addition, several advanced human genome libraries produce genetically specific sequences helping scientists to use genetic information to strengthen detailed medical research.
In addition, the growing need for sequencing technologies due to the increase in disease incidence has increased the demand for genome mapping programs. Such developments are expected to support the rapid growth of the pharmaceutical market in the APAC sector.
Companies mentioned
-
Abbott Laboratories
-
Astrazeneca plc
-
Life Sciences Biocrates AG
-
Bio-Rad Laboratories Inc.
-
Corporal Danaher
-
Eagle Genomics Limited
-
Eli Lilly & Company
-
F Hoffmann-La Roche AG
-
Intomics
-
Laboratory Corporation of America Holdings
-
Nanostring Technologies
-
Novartis AG
-
Pfizer Inc.
-
Qiagen Nv
-
Quest Diagnostics introduced
Key topics covered:
1. Global Acquisition Medicine Market – Summary
2. Business Outlook
2.1. Key views
2.1.1. Presence of biopharmaceutical companies
2.1.2. Invest in gene therapy
2.2. Impact of COVID-19 on Precision Medicine Market
2.3. Supply chain forecast
2.4. Governance Policies & Framework
2.5. Etymology of Precision Medicine
2.6. Porter Force Five Model
2.7. Market Pull Index
2.8. Landscape Seller
2.9. Key Market Strategies
2.9.1. Contracts and Partnerships
2.9.2. Business Expansion & Divestitures
2.9.3. Acquisitions & Mergers
2.9.4. Launch of new product
2.10. Market drivers
2.10.1. High rate of chronic diseases in the aging population
2.10.2. Digital collaboration among research organizations and agencies
2.10.3. Identification of genetic make-up in the human genome
2.11. Market challenges
2.11.1. Drug strict consent process
2.11.2. Security risks associated with data sharing
2.11.3. Changes in the repayment and management process
2.12. Market opportunities
2.12.1. Government investment and private players in cancer treatment
2.12.2. Request for Preventative Care
3. Global Acquisition Medicine Market – By Demand
3.1. Oncology
3.2. Infectious diseases
3.3. Neurology / Physiatry
3.4. Cardiovascular
3.5. Lifestyle and Endocrinology
3.6. Gastroenterology
3.7. Other applications
4. Global Acquisition Medicine Market – by component
4.1. Applied Science
4.1.1. Genomics
4.1.1.1. Pcr
4.1.1.2. Pm Ngs
4.1.1.3. Genome Editing
4.1.1.4. Other Genomics Technologies
4.1.2. Pharmacogenomics
4.1.3. Other applied sciences
4.2. Precision Therapeutics
4.2.1. Clinical trials
4.2.2. Cell therapy
4.2.3. Drug Detection and Investigation
4.2.4. Gene therapy
4.3. Detailed diagnosis
4.3.1. Molecular diagnostics
4.3.1.1. Non-invasive Prenatal Test (Nipt)
4.3.1.2. Companion diagnostics
4.3.1.3. Liquid biopsy
4.3.1.4. Other molecular diagnostics
4.3.2. Medical image
4.3.2.1. Image analytics
4.3.2.2. Computer Aided Verification (Cadx)
4.4. Digital Health and Information Technology
4.4.1. Clinical decision support systems (Cdss)
4.4.2. Data analyzes
4.4.3. Infrastructure
4.4.4. Informatics Genomics
4.4.5. Informatics In-Silico
4.4.6. Mobile health
5. Global Acquisition Medicine Market – Regional Outlook
5.1. North America
5.2. Europe
5.3. Asia-Pacific
5.4. Latin America
5.5. Middle East and Africa
6. Competitive Landscape
6.1. Abbott Laboratories
6.2. Astrazeneca plc
6.3. Life Sciences Biocrates AG
6.4. Bio-Rad Laboratories Inc.
6.5. Corporal Danaher
6.6. Eagle Genomics Limited
6.7. Eli Lilly & Company
6.8. F Hoffmann-La Roche AG
6.9. Intomics
6.10. Laboratory Corporation of America Holdings
6.11. Nanostring Technologies
6.12. Novartis AG
6.13. Pfizer Inc.
6.14. Qiagen Nv
6.15. Quest Diagnostics introduced
7. Research Approach & Scope
For more information on this report, visit https://www.researchandmarkets.com/r/56phon